Tryp has submitted a provisional patent describing novel methods for the formulation, delivery, and dosing of psychedelics. These technologies may reduce the time spent in a disocciative state. The filing also includes a method for “manufacturing the active pharmaceutical ingredient, novel formulations, methods to enhance the safety profile of treatments, and methods to reduce risk of abuse and…


Previous articleatai Life Sciences AG Announces Equity Investment in and Strategic Partnership with IntelGenx Technologies Corp.
Next articleNovamind Partners with Merck for New Treatment-Resistant Depression Trial